In prostate cancer, CD9 has been identified as a candidate gene involved in androgen-deprived cell proliferation through its interaction with IGSF8 [72], suggesting a role of CD9 itself in AR-mediated prostate cancer progression. Here, AR is linked to prostate carcinoma.